Eczacıbaşı

🚨 Reasons for Boycotting Eczacıbaşı Holding

Eczacıbaşı Holding is one of Turkey's largest industrial conglomerates, founded in 1942 and operating in healthcare, consumer goods, building materials, and finance. The company owns iconic brands such as Selpak, Solo, Detan, Defans, Viva, and Maratem in the cleaning and hygiene sector, as well as VitrA and Artema in building products. While the company does not sell weapons directly, it is deeply embedded in the israeli economy and occupation through direct investments by its venture arm Eczacıbaşı Momentum in israeli company Ocon Medical, İstanbul Modern's partnership with israeli art institutions, and the continued flow of profits from consumer products into the israeli technology ecosystem.

1. Direct Investment in israeli Company Ocon Medical via Eczacıbaşı Momentum: Eczacıbaşı Momentum - the corporate venture capital arm of Eczacıbaşı Holding - has listed israeli company Ocon Medical in its official investment portfolio. Ocon Medical is an israeli company specializing in the development of hormone-free intrauterine devices (IUDs) and a drug delivery platform. Ocon's CE-approved products are used by over 100,000 women in 24 countries, and the company is currently working on a drug delivery platform in Phase II clinical trials. Thus, profits generated by Eczacıbaşı from the Turkish market are directly invested in an israeli company contributing to the israeli high-tech ecosystem.Eczacıbaşı Momentum Official Website: Portfolio — Ocon Medical (Hormone-free IUDs, 100,000 women in 24 countries)Crunchbase: Eczacıbaşı Momentum — Corporate Venture Capital Fund (Established 2019)PitchBook: Eczacıbaşı Momentum Investment Portfolio — OCON Therapeutics (June 2024)
2. İstanbul Modern's Partnership with israeli Art Institutions: In January 2026, it was revealed that İstanbul Modern - Eczacıbaşı Holding's flagship art museum - was a member of the Guggenheim Art Pass program, an international membership network that includes the Tel Aviv Museum of Art and the israel Museum in Jerusalem. The revelation sparked outrage in Turkey, with film director Necmi Sancak throwing his award from the Istanbul Film Festival into the trash in protest of "Eczacıbaşı Holding, İKSV, and İstanbul Modern's collaboration with the genocidal israeli regime." Under massive public pressure, İstanbul Modern was forced to announce its withdrawal from the program on January 10, 2026, stating: "We respectfully acknowledge the sensitivity of the public, and announce our decision to terminate our membership in the Guggenheim Art Pass."Yeni Şafak: İstanbul Modern's statement — withdrew from membership after backlash (January 2026)Türkiye Gazetesi: Collaboration with israeli museums drew backlash (January 2026)Habertürk: Art Pass crisis — İstanbul Modern withdrew from membership (January 2026)İstanbul Modern Official Statement: Information (January 2026)
3. Flow of Profits from Consumer Products into the israeli Ecosystem: Eczacıbaşı Holding owns a vast portfolio of consumer brands sold in nearly every Turkish household, including Selpak, Solo, Detan, Defans, Viva, and Maratem in cleaning and hygiene, as well as VitrA and Artema in building products. A portion of the profits generated from these products is redirected, through Eczacıbaşı Momentum, to israeli technology companies such as Ocon Medical. Thus, every purchase of Eczacıbaşı products indirectly contributes to financing the israeli technology ecosystem.Eczacıbaşı Holding Official Website: Our Companies — Selpak, Solo, Detan, Defans, Viva, Maratem, VitrA, ArtemaEczacıbaşı Momentum Official Website: Portfolio Companies — Ocon, Vagustim, Virasoft, Caresyntax
4. Historical Relations with israeli Company Teva Pharmaceutical: According to news reports from 2006, Eczacıbaşı Holding commissioned Merrill Lynch to explore partnership opportunities in the pharmaceutical sector, with israeli company Teva Pharmaceutical Industries - the world's largest generic drug manufacturer - at the forefront of candidates. Reports also indicated that Eczacıbaşı was "close" to Teva at the time. This historical record indicates established commercial relations with israeli pharmaceutical companies.Takvim (Archive): Eczacıbaşı flirting with giants, israeli Teva one step ahead (September 2006)Eczacıbaşı Holding Official Website: EİP Eczacıbaşı İlaç Pazarlama — Partnership with Baxter Group (2016)
5. Stark Double Standards in Crisis Response: Although Eczacıbaşı Holding has taken clear public stances on issues such as the Ukraine war, it has issued no statement condemning the genocide in Gaza. Instead, the company chose "strict silence" regarding the devastation in Gaza, while continuing its investments in israeli companies and its artistic partnerships with israeli institutions. This stark contradiction exposes the company's claims of social responsibility.Yeni Şafak: İstanbul Modern's U-turn (January 2026)Yeni Akit: Slap to art-masked israel collaboration (January 2026)

🌐 Sources

Official and verifiable sources detailing Eczacıbaşı Holding's involvement with israil:

• Eczacıbaşı Momentum Official Website: Portfolio — Ocon Medical investment
• PitchBook: Eczacıbaşı Momentum Investment Portfolio — OCON Therapeutics (June 2024)
• Crunchbase: Eczacıbaşı Momentum — Corporate Venture Capital Fund
• Yeni Şafak: İstanbul Modern's statement (January 2026)
• Türkiye Gazetesi: Collaboration with israeli museums drew backlash (January 2026)
• İstanbul Modern Official Statement: Information (January 2026)
• Takvim (Archive): Eczacıbaşı and Teva Pharmaceutical (September 2006)
• Eczacıbaşı Holding Official Website: Our Companies

Boykot Market has listed the brand information and the final source links verifying the boycott reason above to help you access more details.

Please conduct your own research to be certain. Also, if you find any information incorrect, missing, or erroneous, you can reach us through our contact page. We will get back to you after the necessary reviews.